Article date: January 0001
By: A Kelly, EB Elliott, R Matsuda, N Kaneko, GL Smith, CM Loughrey in Volume 165, Issue 4b, pages 1068-1083
BACKGROUND AND PURPOSE
Reduced cardiac contractility has been associated with disrupted myocardial Ca2+ signalling. The 1,4 benzothiazepine K201 (JTV‐519) acts on several Ca2+ handling proteins and improves cardiac contractility in vivo in a variety of animal models of myocardial dysfunction. However, it is unclear whether this improvement depends on the systemic effects of K201 or if K201 reverses the effects of Ca2+ dysregulation, regardless of the cause.
EXPERIMENTAL APPROACH
The effect of K201 on cardiac mechanical function was assessed in isolated working hearts from adult rabbits, using a ventricular pressure‐volume catheter. In separate experiments, the effect of K201 was investigated in hearts following pharmacologically induced Ca2+ overload using elevated extracellular [Ca2+] ([Ca2+]o) and β‐adrenoceptor stimulation.
KEY RESULTS
K201 induced a concentration‐dependent decline in systolic function (peak pressure, dP/dtmax and preload recruitable stroke work), lusitropy (reduced dP/dtmin and increased end diastolic pressure) and stroke volume, independent of decreased heart rate. In separate experiments, mechanical function in hearts exposed to 4.5 mmol·L−1[Ca2+]o and 150 nmol·L−1 isoprenaline declined until cessation of aortic flow (in 6 out of 11 hearts). However, all hearts perfused with the addition of 1 µmol·L−1 K201 maintained aortic flow and demonstrated significantly improved peak systolic pressures, dP/dtmax and dP/dtmin.
CONCLUSIONS AND IMPLICATIONS
K201 significantly improved mechanical function of the heart during Ca2+ overload. This suggests that K201 can limit the detrimental effects of elevated intracellular Ca2+ and exert beneficial effects on cardiac contractile function, independent of systemic effects previously observed in vivo.
DOI: 10.1111/j.1476-5381.2011.01531.x
View this article